Notably, patients with obesity with an endothelial cell-specific deletion of the ADM receptor display improved insulin sensitivity, which was accompanied by enhanced insulin-stimulated endothelial nitric oxide synthase (eNOS) phosphorylation and increased skeletal muscle perfusion [109]. This evidence concerns the gene NOS3 and obesity due to melanocortin 4 receptor deficiency.